Blood antibody patterns may identify people at risk for IBD years before symptoms
Scientists found the immune system leaves warning signals up to a decade before diagnosis of Crohn's disease and ulcerative colitis.

Antibody patterns in the blood may help doctors identify people at risk of inflammatory bowel disease (IBD) so they can be treated earlier. Scientists found the immune system sends warning signals up to a decade before diagnosis, paving the way for potentially earlier detection and even prevention.
Crohn’s disease and ulcerative colitis, the two main forms of IBD, are typically treated only after symptoms appear, when the gut has already been damaged. For too long, doctors have only been able to treat the disease once the damage is done, and for many people that is too late.
Researchers at the University Medical Centre Groningen, the Icahn School of Medicine at Mount Sinai, and the Medical University of Vienna examined 2,000 blood samples from 500 people. Among the group, 200 people later developed Crohn’s disease, 200 developed ulcerative colitis, and 100 developed neither condition.
In those who later developed Crohn’s disease, antibodies against Epstein-Barr virus were more common, and these differences were visible a decade before diagnosis. The signal was strongest in those who later developed more severe, complicated disease. People who developed ulcerative colitis showed a different pattern, including antibodies against one of the body’s own proteins.
The findings were published in the journal Gut and presented at the United European Gastroenterology meeting in Barcelona. The results show a link rather than proving the infections cause IBD, and the findings need to be confirmed in other groups of people.
James Lindsay, a professor of gastroenterology at Barts Health, said the study provided important insights into the causes of Crohn’s disease and ulcerative colitis. However, he cautioned that the techniques are very much a research tool and are not yet ready for the clinic.
Key facts
- The immune system sends warning signals up to a decade before an IBD diagnosis.
- Researchers examined 2,000 blood samples from 500 people to identify antibody patterns.
- Antibodies against Epstein-Barr virus were more common in those who later developed Crohn's disease.
Three perspectives
Neutral
The research identified specific antibody patterns in blood samples that correlate with the later development of Crohn's disease and ulcerative colitis.
Positive
The study provides important insights that could potentially add new tools to help identify those at risk of IBD.
Negative
The techniques used in the study are currently a research tool and are not yet ready for clinical use.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.
